The death of a Pinduoduo Inc employee has renewed criticism of the long hours commonly practiced at China’s technology companies, which are already under scrutiny by regulators for anti-competitive business practices.
The e-commerce company yesterday confirmed that an employee died last week after working past midnight, without providing additional details.
That sparked a social media backlash against the company and the relentless working schedules expected of its employees.
The so-called “996” office schedule — 9am to 9pm, six days a week, plus overtime — has previously spurred criticism following complaints from employees and deaths.
Technology billionaires, such as Alibaba Group Holding Ltd founder Jack Ma (馬雲) and JD.com Inc founder Richard Liu (劉強東), have endorsed the practice as necessary for survival in an intensely competitive industry and the key to accumulating personal wealth.
The online criticism adds to the challenges for China’s largest technology companies, which spent the past year fending off efforts by Washington to curb their growth, while navigating heightened regulatory scrutiny at home.
Despite that, Pinduoduo emerged relatively unscathed with its shares rising to a record high on Wednesday last week.
The shares ended last year up nearly 370 percent, helping to elevate founder Colin Huang (黃崢) to the position of China’s second-richest person, according to the Bloomberg Billionaires Index.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS